As of Feb 15
| +2.85 / +4.28%|
The 16 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 86.00, with a high estimate of 100.00 and a low estimate of 67.00. The median estimate represents a +23.87% increase from the last price of 69.43.
The current consensus among 18 polled investment analysts is to Buy stock in Teladoc Health Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.